45 related articles for article (PubMed ID: 30067108)
1. Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United States.
Keyloun KR; Weber DJ; Gardstein BM; Berger A; Gillard P; Ganz ML
Hosp Pract (1995); 2018 Dec; 46(5):278-286. PubMed ID: 30067108
[No Abstract] [Full Text] [Related]
2. Hospital costs for patients with lower extremity cellulitis: a retrospective population-based study.
Challener D; Marcelin J; Visscher S; Baddour L
Hosp Pract (1995); 2017 Dec; 45(5):196-200. PubMed ID: 28944703
[TBL] [Abstract][Full Text] [Related]
3. HIV disease burden, cost, and length of stay in Portuguese hospitals from 2000 to 2010: a cross-sectional study.
Catumbela E; Freitas A; Lopes F; Mendoza Mdel C; Costa C; Sarmento A; da Costa-Pereira A
BMC Health Serv Res; 2015 Apr; 15():144. PubMed ID: 25889920
[TBL] [Abstract][Full Text] [Related]
4. Length of stay and associated costs of obesity related hospital admissions in Ireland.
Vellinga A; O'Donovan D; De La Harpe D
BMC Health Serv Res; 2008 Apr; 8():88. PubMed ID: 18426608
[TBL] [Abstract][Full Text] [Related]
5. Impact of first-line dalbavancin for cellulitis on hospital admissions and costs: a case series.
Ben-Sassi K; Sarwar S
J Glob Antimicrob Resist; 2024 May; ():. PubMed ID: 38821442
[TBL] [Abstract][Full Text] [Related]
6. Methods to Reduce Cost of Treatment in Childhood Bone and Joint Infection: A Systematic Review.
Hunter S; Crawford H; Ao BT; Grant C
JBJS Rev; 2024 May; 12(5):. PubMed ID: 38814570
[TBL] [Abstract][Full Text] [Related]
7. How Well Do All Patient Refined-Diagnosis-Related Groups Explain Costs of Pediatric Cancer Chemotherapy Admissions in the United States?
Russell H; Street A; Ho V
J Oncol Pract; 2016 May; 12(5):e564-75. PubMed ID: 27118158
[TBL] [Abstract][Full Text] [Related]
8. Single Intravenous Dose Dalbavancin Pathway for the Treatment of Acute Bacterial Skin and Skin Structure Infections: Considerations for Emergency Department Implementation and Cost Savings.
LoVecchio F; McCarthy MW; Ye X; Henry AD; Doan QV; Lock JL; Riccobene T; Lyles RD; Talan DA
J Emerg Med; 2024 Mar; ():. PubMed ID: 38825531
[TBL] [Abstract][Full Text] [Related]
9. The cost implications of Wilson disease among hospitalized patients: analysis of USA hospitals.
Lee DU; Harmacinski A; Bahadur A; Lee KJ; Chou H; Shaik MR; Chou H; Fan GH; Kwon J; Ponder R; Chang K; Lee K; Lominadze Z
Eur J Gastroenterol Hepatol; 2024 Jul; 36(7):929-940. PubMed ID: 38652529
[TBL] [Abstract][Full Text] [Related]
10. Costs of hospital admissions due to COVID-19 in the federal capital of Brazil: a study based on hospital admission authorizations.
Pereira ACEDS; Gallo LG; Oliveira AFM; de Oliveira MRF; Peixoto HM
Braz J Infect Dis; 2024; 28(2):103744. PubMed ID: 38670167
[TBL] [Abstract][Full Text] [Related]
11. Emergency department care of ABSSSI with dalbavancin infusion, direct discharge, and outpatient telemedicine follow up: a study protocol.
Durante-Mangoni E; Riccardi A; Guarino M; Cesaro F; Lugarà M; Mascolo S; Morelli L; Natale V; Andreoni M
J Chemother; 2023 Sep; 35(5):397-403. PubMed ID: 36264157
[TBL] [Abstract][Full Text] [Related]
12. Direct Costs of COVID-19 Inpatient Admissions in a Portuguese Tertiary Care University Centre.
Seringa J; Pedreiras S; Freitas MJ; Valente de Matos R; Rocha J; Millett C; Santana R
Port J Public Health; 2022 Apr; 40(1):26-34. PubMed ID: 37753497
[TBL] [Abstract][Full Text] [Related]
13. Diagnosing, assessing and managing cellulitis.
Newton H
Nurs Stand; 2024 Jan; 39(2):39-44. PubMed ID: 38044818
[TBL] [Abstract][Full Text] [Related]
14. Economic evaluation of the treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSIs) from the national payer perspective: introduction of a new treatment to the patient journey. A simulation of three European countries.
Marcellusi A; Viti R; Sciattella P; Sarmati L; Streinu-Cercel A; Pana A; Espin J; Horcajada JP; Favato G; Andretta D; Soro M; Andreoni M; Mennini FS
Expert Rev Pharmacoecon Outcomes Res; 2019 Oct; 19(5):581-599. PubMed ID: 30714834
[No Abstract] [Full Text] [Related]
15. Current and future options for treating complicated skin and soft tissue infections: focus on fluoroquinolones and long-acting lipoglycopeptide antibiotics.
Eckmann C; Tulkens PM
J Antimicrob Chemother; 2021 Nov; 76(Suppl 4):iv9-iv22. PubMed ID: 34849999
[TBL] [Abstract][Full Text] [Related]
16. Update on the epidemiology of healthcare-acquired bacterial infections: focus on complicated skin and skin structure infections.
Wilcox MH; Dryden M
J Antimicrob Chemother; 2021 Nov; 76(Suppl 4):iv2-iv8. PubMed ID: 34849996
[TBL] [Abstract][Full Text] [Related]
17. Ceftobiprole Compared With Vancomycin Plus Aztreonam in the Treatment of Acute Bacterial Skin and Skin Structure Infections: Results of a Phase 3, Randomized, Double-blind Trial (TARGET).
Overcash JS; Kim C; Keech R; Gumenchuk I; Ninov B; Gonzalez-Rojas Y; Waters M; Simeonov S; Engelhardt M; Saulay M; Ionescu D; Smart JI; Jones ME; Hamed KA
Clin Infect Dis; 2021 Oct; 73(7):e1507-e1517. PubMed ID: 32897367
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Real-World Evaluation of Outcomes in Patients with Skin and Soft Structure Infections Treated with Tedizolid in an Outpatient Setting.
Kullar R; Puzniak LA; Swindle JP; Lodise T
Infect Dis Ther; 2020 Mar; 9(1):107-117. PubMed ID: 31974828
[TBL] [Abstract][Full Text] [Related]
19. Dalbavancin Reduces Hospital Stay and Improves Productivity for Patients with Acute Bacterial Skin and Skin Structure Infections: The ENHANCE Trial.
McCarthy MW; Keyloun KR; Gillard P; Choi JJ; Pickell N; Copp R; Walsh TJ
Infect Dis Ther; 2020 Mar; 9(1):53-67. PubMed ID: 31713130
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
